Format

Send to

Choose Destination
Int J Surg. 2015 Dec;24(Pt A):33-8. doi: 10.1016/j.ijsu.2015.10.027. Epub 2015 Oct 23.

Long term subjective cure rate, urinary tract symptoms and dyspareunia following mesh augmented anterior vaginal wall prolapse repair.

Author information

1
Department of Obstetrics and Gynecology, Soroka University Medical Center, Beer Sheva 85025, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva 8410501, Israel. Electronic address: adiyehud@bgu.ac.il.
2
Department of Obstetrics and Gynecology, Chaim Sheba Medical Center, Tel Hashomer 52621, Israel. Electronic address: talianoam@gmail.com.
3
Department of Obstetrics and Gynecology, Soroka University Medical Center, Beer Sheva 85025, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva 8410501, Israel; Clinical Research Center, Soroka University Medical Center, Beer Sheva 85025, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva 8410501, Israel. Electronic address: yaelkup@yahoo.com.
4
Urogynecology, Department of Obstetrics and Gynecology, Galilee Medical Center, Nahariya, and the Faculty of Medicine in the Galilee, Bar Ilan University, Safed, Israel; Assuta Medical Centers, Tel Aviv and Rishon LeZion, Israel. Electronic address: mneuman@netvision.net.il.
5
Urogynecology Unit, Department of Obstetrics and Gynecology, Helen Schneider Hospital for Women, Petach Tikva 49100, Affiliated with Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, Israel. Electronic address: Haimkr@clalit.org.il.

Abstract

INTRODUCTION:

The aim of this study was to assess patient-centered long term outcomes following anterior vaginal repair with mesh.

METHODS:

In January 2015, we identified 124 women who underwent anterior pelvic floor repair with mesh between January 2006 and February 2009. Patient records were reviewed and demographic, clinical, intra-operative and post-operative follow-up data retrieved. Telephone interviews were conducted to access information on clinical outcomes. Associations between baseline characteristics and long term symptoms were assessed by multivariable logistic regression models.

RESULTS:

Seventy-nine women were reached and consented to participate. Patients were interviewed 79-104 months after surgery. Their mean age at the time of surgery was 62.48 ± 9.53 years; all had stage III cystocele with a mean POP Q point Ba of 5.32 ± 1.47. Twenty-four (30%) had a previous hysterectomy and 26 (33%) had a previous pelvic organ prolapse or stress urinary incontinence operation. At telephone interviews, recurrence of prolapse symptoms was reported by 11 (13.9%) patients, mostly in the posterior compartment. Only 6 needed a corrective procedure. One patient had her mesh removed due to dyspareunia. Eleven (13.9%) reported lower urinary tract symptoms other than prolapse, as follows: stress urinary incontinence (1), overactive bladder (8) and dyspareunia (2).

CONCLUSION:

Long term rates of recurrent prolapse, dyspareunia and lower urinary tract symptoms were low for patients who underwent anterior vaginal wall mesh augmentation surgery for symptomatic cystoceles.

KEYWORDS:

Adverse symptoms; Anterior vaginal prolapse; Long term outcomes; Mesh augmentation; Overactive bladder; Recurrent prolapse surgery

PMID:
26525268
DOI:
10.1016/j.ijsu.2015.10.027
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center